HaploPharma Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

HaploPharma General Information

Description

Provider of genomic analysis services intended to promote personalized medicine and improve personal healthcare in an aging society. The company offers genome sequencing, diagnostic device development, and microarray-based testing, enabling healthcare providers and pharmaceutical researchers to advance precision diagnostics and accelerate drug discovery.

Contact Information

Website
www.haplopharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Tohoku University School of Medicine Building 5, 1st Floor
  • 2-1 Seiryo-cho, Aoba-ku
  • Sendai, Miyagi 980-8575
  • Japan
+81
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Tohoku University School of Medicine Building 5, 1st Floor
  • 2-1 Seiryo-cho, Aoba-ku
  • Sendai, Miyagi 980-8575
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HaploPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 01-Nov-2020 Completed Generating Revenue
1. Early Stage VC 01-Jan-2007 Completed Generating Revenue
To view HaploPharma’s complete valuation and funding history, request access »

HaploPharma Patents

  • 30

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • Pending

  • Expiring in next 12 mo

HaploPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3614146-A1 Method for detecting aldosterone and renin Active 21-Apr-2017
EP-3614146-A4 Method for detecting aldosterone and renin Active 21-Apr-2017
WO-2018194152-A1 Method for detecting aldosterone and renin Inactive 21-Apr-2017
EP-3614147-A1 Method for detecting specimen substance using multiphase polymer fine particles Active 21-Apr-2017
EP-3614147-A4 Method for detecting specimen substance using multiphase polymer fine particles Active 21-Apr-2017 G01N33/5434
To view HaploPharma’s complete patent history, request access »

HaploPharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HaploPharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
TOHOKU University Venture Partners Venture Capital Minority
Bio Frontier Partners Venture Capital Minority
To view HaploPharma’s complete investors history, request access »

Ready to get started?

Request a free trial

HaploPharma FAQs

  • When was HaploPharma founded?

    HaploPharma was founded in 2004.

  • Where is HaploPharma headquartered?

    HaploPharma is headquartered in Sendai, Japan.

  • What is the size of HaploPharma?

    HaploPharma has 10 total employees.

  • What industry is HaploPharma in?

    HaploPharma’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is HaploPharma a private or public company?

    HaploPharma is a Private company.

  • What is HaploPharma’s current revenue?

    The current revenue for HaploPharma is .

  • Who are HaploPharma’s investors?

    TOHOKU University Venture Partners and Bio Frontier Partners have invested in HaploPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process